Esbriet 267 MG tablet 270S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ7W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,449
Award facts
- Contract value 100% obligated
- $10,449.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 14, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 270 tablets of Esbriet 267 mg at a ceiling value of $10,449.43 with firm fixed pricing. The award is not set-aside and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. Esbriet (pirfenidone) is a pharmaceutical treatment for idiopathic pulmonary fibrosis, reflecting the DLA's role in supplying specialized medications to military treatment facilities and veteran healthcare programs. The place of performance is Conshohocken, Pennsylvania, the corporate headquarters of AmerisourceBergen Drug Corp.
AmerisourceBergen, as a major pharmaceutical distributor and critical federal healthcare vendor, maintains extensive contract relationships with the DLA Medical Supply Chain. The company's parent, Cencora, Inc., competes on a full and open basis for federal pharmaceutical procurement and serves as a primary supplier of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support global military healthcare operations. This delivery order exemplifies the routine pharmaceutical supply missions executed through the established IDC vehicle, ensuring the Department of Defense has access to specialized medications necessary for comprehensive patient care.
Quick answers
Who was awarded contract SPE2DR26FCZ7W?
SPE2DR26FCZ7W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ7W worth?
The government has obligated $10,449 on SPE2DR26FCZ7W.
Is contract SPE2DR26FCZ7W an order under another contract?
Yes. SPE2DR26FCZ7W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ7W competed?
The extent of competition for SPE2DR26FCZ7W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award